TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Depression severity score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Molecular alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants achieving suppression of HBV DNA with HBsAg loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Total time for airway management
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Anterior Pelvic Tilt (APT) Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical live birth rate
Endpoint domain: Mortality/survival
Primary endpoint: Parental activation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 16 week disease control rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Muscle Carnosine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline Plasma Beta-alanine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Validity of ObsQoR-10F questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Craniocervical Flexion Test (CCFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck Flexor Endurance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events (AE) and serious AE (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of subjects who experienced at least 1 treatment-emergent serious adverse event (TE SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of subjects who experienced a treatment-emergent dose-limiting toxicity (TE DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of utilizable blastocysts obtained
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Preparedness for self-monitoring and self-management of oral anticoagulation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in Short Physical Performance Battery (SPPB)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean satisfaction outcome
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Pain Unpleasantness Numeric Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety of intra-articular administration of AlloGen Liquid
Endpoint domain: Adverse events/effects
Primary endpoint: weight change in kilograms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Progression of carotid intima media thickness (CIMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of preterm infants who developed necrotizing enterocolitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pain scores at 1st month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores at 3rd month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation of autoimmunity, inflammatory, and immunological profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Processing Speed domain score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: serum ammonium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: branch instability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in clot lysis time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total Discharge Opioid Burden
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Maximum Observed Serum Concentration (Cmax) for Nirsevimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Reach Maximum Observed Serum Concentration (Tmax) for Nirsevimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Serum Concentration-Time Curve From Time 0 to 150 Days (AUC0-150) for Nirsevimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal cortex microvessel density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Renal cortex microvessel diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Renal blood flow velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of caregivers that enroll and complete study visit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Average time to completion of the educational tool
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average time to complete the study visit
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Severity of endogenetic alopecia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic convergence of mFG and LS scales
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Hyponatremia and Hypernatremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Electrolyte and fluid balance outcomes
Primary endpoint: Frailty composite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCt of Olmesartan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of Olmesartan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCt of Dapagliflozin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of returned FIT Kits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Primary post-partum bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion maintaining comprehensive disease control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Error of size estimation for colorectal polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from baseline in systolic AOBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in Glucocorticoid Toxicity Index (GTI) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 100 mm Visual Analogue Scale (VAS) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Skin barrier function by Trans-Epidermal Water Loss (TEWL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: User experience and subjective burden questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients recovered to 100×10^9/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of patients with mean Hb ≥ 11.0 g/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Thigh Muscle Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leg Muscle Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Cleveland Constipation Score (CCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in the score of Bristol fecal trait scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Composite of Major Adverse Device-Related Events
Endpoint domain: Adverse events/effects
Primary endpoint: Blood DHA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cervical mucus DHA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cardiac events in patient level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiac events in lesion level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Nausea Vomiting Visual Comparison Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Determination of Levels of Biochemical Parameters in Blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Acceptability of bedside CPET
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recruitment rate (uptake of bedside CPET)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adverse or unexpected events report
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in symptom intensity
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Quality of Recovery total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Malaria Incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Chemopreventive Efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of resistance markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detected abnormalities - Composite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total pethidine consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Smartphone Addiction Scale-Short Version (SAS-SV)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: The visual analogue scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: frequency of treatment-related safety and adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: minimum inhibitory concentration of the medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 48-hour delta SOFA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiration flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Respiration volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Occurrence of solicited local reactogenicity signs and symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency, duration and severity of solicited and unsolicited adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with abnormal laboratory test results
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of enhanced recovery after pancreatico-dudenectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: alveolar ridge width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score after cesarean delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perianal fistula incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Opioids requirements intraoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score in the post-anesthesia care unit (PACU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best Objective Response Rate (ORR) Within 6 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression Free Survival (PFS) at 18 Weeks
Endpoint domain: Mortality/survival
Primary endpoint: Pain trajectories in hand OA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nausea Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety Level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in E-RS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: persistence of a full-blown DMDD diagnostic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric balance scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants who complete enrollment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Transitions of Care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Rescue Seizure Therapy for Children with Epilepsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Genetic Testing for Global Developmental Delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adolescent Depression Screening
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physician-patient communication Survey Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient engagement Survey Score
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Bacterial STI's
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Diagnostic correlation with microscopic otoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic correlation with CT scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic correlation with Magnetic Resonance Imaging (MRI)s
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic correlation with audiologic testing results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic correlation with surgical reports
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic correlation with pathology reports
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in urine leakage amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Time taken for seizures to be controlled
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percent inhibition of SARS-CoV-2 surrogate Virus Neutralization Test neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: End growth below 30 degrees Cobb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Growth above 50 degrees Cobb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global scar score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes in National Institute of Health stroke scale (NIHSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Epidural-related morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of clinical resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of radiological resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Text Messages Completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Assessment of Muscle Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of Muscle Performance: 4-Meter Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of Muscle Performance: Sit-to-Stand Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Depression Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of Anxiety Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Gastric volume 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastric volume 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Primary immunogenicity outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum phosphate stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of Participants Who Achieve Clinical Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State-Anxiety Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Core body temperature in centigrade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight in kilogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in upper extremity functionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Good quality cardiac data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Good quality respiratory data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Patient disease progression classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: One year patency rate of hemodialysis catheters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Newborn Skin Condition Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes in insulin and glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LAA Closure Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Composite of Ischemic Stroke or System Embolism
Endpoint domain: Adverse events/effects
Primary endpoint: Disease-free Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: Changes in quality of life (EQ-5D-5L) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective rate of hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activity recovery of first dose
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: gut bacterial flora
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Visualization of All Major Anatomic Regions in the Stomach
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Sensitivity of mass detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical scales for Progressive Supranuclear Palsy (PSP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical scales for Multiple System Atrophy (MSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in characteristics of functional network architecture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Initial response to pain desensitization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Geometric Mean Fold Rise (GMFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Geometric Mean Titers (GMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Geometric Mean Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stress Recovery Change Following Intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting HRV Change Following Intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in T cell activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants Who Agree to Participate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Participants Who Provide Data
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: ICD-10 codes for each admission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: fMRI Hippocampal BOLD values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of postoperative infectious complication
Endpoint domain: Adverse events/effects
Primary endpoint: Uptake of cascade screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Ankle talar cartilage thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Overall survival rate at 36 months
Endpoint domain: Mortality/survival
Primary endpoint: Sexting
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Intra-muscular pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Astigmatism (Keratometric reading)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Treatment-Emergent Signs and Symptoms/ Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: PAP adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status